Reduce Risk of Human Error in Point-of-Care Testing 09 Sep 2010: The Randox Acusera range of liquid ready to use quality controls are convenient and easy to use making them ideal for use in point-of-care testing. By eliminating the need for dilution or reconstitution the risk of human error is minimised. Randox Laboratories Ltd
Olympus Introduces Complete Documentation Package for Clinical and Research Imaging 08 Sep 2010: LabSens provides a workflow-oriented user interface, ensuring that the key functions for digital imaging, analysis and documentation are clearly presented and easy to use. This is achieved by seamlessly combining the new Olympus BX3 clinical microscopes with digital-imaging cameras, as well as automation components. Olympus Europa Holding GmbH
Olympus Introduces the BX3 Clinical Microscope Range 08 Sep 2010: Olympus announces the new BX3 range of upright clinical microscopes featuring the BX43 system microscope and the BX46 ergonomic screening microscope. The BX3 clinical microscopes incorporate the advanced Olympus UIS2 optical components and are uniquely adaptable, ensuring the ultimate level of imaging flexibility and ergonomic operation. Olympus Europa Holding GmbH
A Guide to Absolute Counting on the Accuri C6 Flow Cytometer 03 Sep 2010: This technical note discusses features of the Accuri C6 Flow Cytometer® for simplifying cell analysis by performing absolute cell counts, eliminating the need for counting beads, or dual-platform hemacytometer counts. The microprocessor-controlled peristaltic pump system allows the sample volume pulled per run to be determined. Accuri Cytometers, Inc.
New Diagnostic Test Helping in the Fight Against Ovarian Cancer 20 Aug 2010: A new test for ovarian cancer was demonstrated to be 99% to 100% accurate over 100 patient samples by Researchers at Georgia Institute of Technology. This new diagnostic technique is able to test a single drop of blood serum using JEOL's AccuTOF™-DART® mass spectrometer. JEOL USA
In Vivo Monitoring of Fluorescently Labeled Cancer Cells 18 Aug 2010: This application poster demonstrates that both bioluminescence and fluorescence can be used to measure primary tumor growth and metastasis in vivo. Tumor progressions were monitored non-invasively and in real time using an enclosed imaging system containing a cooled CCD camera. Caliper Life Sciences
Use of Antibodies In Small Animal Molecular Imaging 18 Aug 2010: In vivo imaging enables the natural course of a disease or experimental model to be monitored. This application note discusses the use of fluorescently labeled primary antibodies for looking at protein expression in vivo imaging. The use of antibodies allows researchers to quickly determine if the test antibody begins to target undesired organs such as the kidneys or livers. Carestream Molecular Imaging